The conclusion from these experiments was that MACS sorting for CD49A by itself was not sufficient to markedly improve the therapeutic activity in the diabetes model, in line with the equivalent levels in the amount of human C-peptide found in the blood of the mice. The gene discussed is ITGA1; the disease is diabetes mellitus.